Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Active not recruiting 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 18 Neoplasms 18 Breast Neoplasms 16 Colorectal Neoplasms 12 Carcinoma, Non-Small-Cell Lung 11 Lung Neoplasms 10 Urinary Bladder Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 6 Hematopoietic and Lymphatic System Neoplasm 6 Hematologic Neoplasms 6 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Triple Negative Breast Neoplasms 4 Leukemia, Myeloid, Acute 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Multiple Myeloma 3 Mouth Neoplasms 3 Hematopoietic and Lymphoid System Neoplasm 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Renal Cell 3 Sarcoma 2 Radiodermatitis 2 Peritoneal Neoplasms 2 Pathologic Complete Response 2 Parotid Neoplasms 2 Motor Activity 2 Melanoma 2 Malignant Solid Neoplasm 2

Interventions

Cyclophosphamide 27 fludarabine 18 Rituximab 17 obinutuzumab 11 venetoclax 9 Bendamustine Hydrochloride 9 Lenalidomide 8 zanubrutinib 6 Prednisone 6 Doxorubicin 6 Blood Specimen Collection 6 pembrolizumab 5 fludarabine phosphate 5 Biopsy 5 ibrutinib 4 glofitamab 4 Vincristine 4 Trimethoprim, Sulfamethoxazole Drug Combination 4 Exercise 4 loncastuximab tesirine 3 gamma-Globulins 3 axicabtagene ciloleucel 3 acalabrutinib 3 Temozolomide 3 Surveys and Questionnaires 3 Palliative Care 3 Mycophenolic Acid 3 Methotrexate 3 Mesna 3 Magnetic Resonance Spectroscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma × Standard of Care × Clear all

NCT05006482 2026-01-13

GEM-S

University of Rochester

Phase 3 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡